232 related articles for article (PubMed ID: 27760432)
1. The Efficacy of Antimuscarinics Alone or in Combination with Alpha-Blockers for the Treatment of Ureteral Stent-Related Symptoms: A Systematic Review and Meta-Analysis.
Yan H; Wang Y; Sun R; Cui Y
Urol Int; 2017; 99(1):6-13. PubMed ID: 27760432
[TBL] [Abstract][Full Text] [Related]
2. Effects of α-Blockers, Antimuscarinics, or Combination Therapy in Relieving Ureteral Stent-Related Symptoms: A Meta-Analysis.
Zhou L; Cai X; Li H; Wang KJ
J Endourol; 2015 Jun; 29(6):650-6. PubMed ID: 25491604
[TBL] [Abstract][Full Text] [Related]
3. The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
Wang J; Zhang X; Zhang T; Mu J; Bai B; Lei Y
World J Urol; 2017 Nov; 35(11):1669-1680. PubMed ID: 28550362
[TBL] [Abstract][Full Text] [Related]
4. PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis.
Zhang YM; Chu P; Wang WJ
Medicine (Baltimore); 2017 Feb; 96(7):e6098. PubMed ID: 28207522
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort.
Lamb AD; Vowler SL; Johnston R; Dunn N; Wiseman OJ
BJU Int; 2011 Dec; 108(11):1894-902. PubMed ID: 21453351
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
Yan H; Zong H; Cui Y; Li N; Zhang Y
J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
[TBL] [Abstract][Full Text] [Related]
7. Antimuscarinics and α-blockers or α-blockers monotherapy on lower urinary tract symptoms--a meta-analysis.
Hao N; Tian Y; Liu W; Wazir R; Wang J; Liu L; Wang K; Li H
Urology; 2014 Mar; 83(3):556-62. PubMed ID: 24361007
[TBL] [Abstract][Full Text] [Related]
8. The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial.
Ragab M; Soliman MG; Tawfik A; Abdel Raheem A; El-Tatawy H; Abo Farha M; Magdy M; Elashry O
Int Urol Nephrol; 2017 Jun; 49(6):961-966. PubMed ID: 28260223
[TBL] [Abstract][Full Text] [Related]
9. Is there a role for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis.
Yakoubi R; Lemdani M; Monga M; Villers A; Koenig P
J Urol; 2011 Sep; 186(3):928-34. PubMed ID: 21791359
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Alpha-Blockers and Antimuscarinics in Improving Ureteral Stent-Related Symptoms: A Meta-Analysis.
Gao Y; Liang H; Liu L; Gurioli A; Wu W
Urol J; 2019 Jun; 16(3):307-311. PubMed ID: 30120759
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.
Dahm P; Brasure M; MacDonald R; Olson CM; Nelson VA; Fink HA; Rwabasonga B; Risk MC; Wilt TJ
Eur Urol; 2017 Apr; 71(4):570-581. PubMed ID: 27717522
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Ureteral Stent-Related Symptoms.
Pecoraro A; Peretti D; Tian Z; Aimar R; Niculescu G; Alleva G; Piana A; Granato S; Sica M; Amparore D; Checcucci E; Manfredi M; Karakiewicz P; Fiori C; Porpiglia F
Urol Int; 2023; 107(3):288-303. PubMed ID: 34818261
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison.
He F; Man LB; Li GZ; Liu N
Drug Des Devel Ther; 2016; 10():1783-93. PubMed ID: 27307709
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms.
Maldonado-Avila M; Garduno-Arteaga L; Jungfermann-Guzman R; Manzanilla-Garcia HA; Rosas-Nava E; Procuna-Hernandez N; Vela-Mollinedo A; Almazan-Trevino L; Guzman-Esquivel J
Int Braz J Urol; 2016; 42(3):487-93. PubMed ID: 27286111
[TBL] [Abstract][Full Text] [Related]
15. Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
Lenfant L; Pinar U; Roupret M; Mozer P; Chartier-Kastler E; Seisen T
J Urol; 2023 Feb; 209(2):314-324. PubMed ID: 36395428
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
El-Nahas AR; Tharwat M; Elsaadany M; Mosbah A; Gaballah MA
World J Urol; 2016 Jul; 34(7):963-8. PubMed ID: 26453222
[TBL] [Abstract][Full Text] [Related]
17. Ureteral Stent-Associated Pain: A Review.
Koprowski C; Kim C; Modi PK; Elsamra SE
J Endourol; 2016 Jul; 30(7):744-53. PubMed ID: 27125392
[TBL] [Abstract][Full Text] [Related]
18. Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
Jian Z; Chen Y; Liu Q; Liao B; Yang T; Li H; Wang K
World J Urol; 2019 Feb; 37(2):289-297. PubMed ID: 30030658
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs.
Sun X; Guan W; Liu H; Tang K; Yan L; Zhang Y; Zeng J; Chen Z; Xu H; Ye Z
BMC Urol; 2018 May; 18(1):30. PubMed ID: 29724204
[TBL] [Abstract][Full Text] [Related]
20. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review.
Kaplan SA; Roehrborn CG; Abrams P; Chapple CR; Bavendam T; Guan Z
Int J Clin Pract; 2011 Apr; 65(4):487-507. PubMed ID: 21210910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
